1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow neoadjuvant EC-paclitaxel chemotherapy: new trials by email Literature Review of neoadjuvant EC-paclitaxel chemotherapy trials Research Report on neoadjuvant EC-paclitaxel chemotherapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Immunotherapy in Combination With Chemotherapy in HER2-negative Inflammatory Breast Cancer Pembrolizumab Injection, neoadjuvant EC-paclitaxel chemotherapy - Inflammatory Breast Cancer | Phase 2 | Active not recruiting | Institut Paoli-Calmettes | 52 | 2018-08-29 | 2025-09-12 |
Inflammatory Breast Neoplasms (1)
France (1)
2016 (1)